Market Trends of Germany Drug Delivery Devices Industry
Cancer is Expected to Show a Significant Growth in the Market during the Forecast Period
Cancer in the applications segment is expected to contribute significantly to the growth of the market, owing to factors such as the rising number of cancer cases being reported in the country. According to the estimates of the Globocan 2018, there are about 608,742 new cases of cancer in Germany. While five most frequent cancers include breast, lung, prostate, colorectum, and bladder cancer. Due to this high prevalence of cancer, increasing efforts are being made in R&D for the development of novel drug delivery systems for providing a better treatment in the patients. The use of innovative technologies in drug deliveries for cancer treatment is driving the market in this segment.
Drug delivery systems like nano-size structures-based pharmaceutical formulations (e.g., liposomes, polymeric nanoparticles, electrosprayed particles, and nanosuspension) have demonstrated shown better administration of drugs in case of cancer treatment. Thus, overall a positive growth is expected in this segment during the forecast period.
